| LEADER 00000nam a2200385Ia 4500 |
| 001 13399121700 |
| 003 ULIBM |
| 008 150620s2015 xxua 001 0 eng d |
| 020 ^a9781455770533
|
| 020 ^a9781455751488
|
| 060 04 ^aQV4^bK26p ^c2015
|
| 100 1 ^aKee, Joyce LeFever
|
| 245 00 ^aPharmacology :^ba patient-centered nursing processapproach /^cJoyce LeFever Kee, Evelyn R. Hayes, Linda E.McCuistion, Lisa A. Hollett
|
| 246 3 ^aStudy guide for pharmacology
|
| 250 ^a8th ed.
|
| 260 ^aSt. Louis :^bElsevier Saunders,^c2015
|
| 300 ^axv, 971 p. :^bcol. ill. ;^c28 cm.
|
| 500 ^a^"Study guide prepared by Lisa A. Hollett^"
|
| 500 ^aPrevious edition has subtitle: ^"a nursing processapproach.^"
|
| 504 ^aIncludes bibliographical references and index
|
| 505 0 ^aDrug action: pharmaceutic, pharmacokinetic, andpharmacodynamic phases -- The drug approval process --Cultural and pharmacogenetic considerations -- Druginteractions and over-the-counter drugs -- Drugs of abuse-- Herbal therapies -- Pediatric pharmacology -- Geriatricpharmacology -- Collaboration in community settings -- Therole of the nurse in drug research -- The nursing processin patient-centered pharmacotherapy -- Safety and qualityin pharmacotherapy -- Medication administration --Medications and calculations -- Vitamin and mineralreplacement -- Fluid and electrolyte replacement --Nutritional support -- Adrenergic agonists and adrenergicblockers -- Cholinergic agonists and anticholinergics --Central nervous system stimulants -- Central nervoussystem depressants -- Anticonvulsants -- Drugs forneurologic disorders: Parkinsonism and Alzheimer^'s disease-- Drugs for neuromuscular disorders: myasthenia gravis,multiple sclerosis, and muscle spasms -- Antiinflammatorydrugs -- Nonopioid and opioid analgesics -- Antipsychoticsand anxiolytics -- Antidepressants and mood stabilizers --Penicillins and cephalosporins -- Macrolides,tetracyclines, aminoglycosides, and fluoroquinolones --Sulfonamides --
|
| 505 0 ^aAntituberculars, antifungals, peptides, and metronidazole-- Antivirals, antimalarials, and anthelmintics -- Drugsfor urinary tract disorders -- HIV- and AIDS-related drugs-- Vaccines -- Anticancer drugs -- Targeted therapies totreat cancer -- Biologic response modifiers -- Drugs forupper respiratory disorders -- Drugs for lower respiratorydisorders -- Cardiac glycosides, antianginals, andantidysrhythmics -- Diuretics -- Antihypertensives --Anticoagulants, antiplatelets, and thrombolytics --Antihyperlipidemics and peripheral vasodilators -- Drugsfor gastrointestinal tract disorders -- Antiulcer drugs --Drugs for eye and ear disorders -- Drugs for dermatologicdisorders -- Endocrine drugs: pituitary, thyroid,parathyroid, and adrenal disorders -- Antidiabetics --Female reproductive cycle I: pregnancy and preterm labordrugs -- Female reproductive cycle II: labor, delivery,and preterm neonatal drugs -- Postpartum and newborn drugs-- Drugs for women^'s reproductive health and menopause --Drugs for men^'s health and reproductive disorders -- Drugsfor disorders in women^'s health, infertility, and sexuallytransmitted infections -- Adult and pediatric emergencydrugs -- Appendix A: Therapeutic drug monitoring --Appendix B: Selected potential weapons of bioterrorism
|
| 650 2 ^aPharmacological Phenomena^vNurses^' Instruction
|
| 650 2 ^aDrug Therapy^vNurses^' Instruction
|
| 650 2 ^aPatient-Centered Care^vNurses^' Instruction
|
| 650 2 ^aPharmaceutical Preparations^vNurses^' Instruction
|
| 700 1 ^aHayes, Evelyn R.
|
| 700 1 ^aMcCuistion, Linda E.
|
| 700 1 ^aHollett, Lisa A.
|
| 945 ^p4900^l0^i46711
|
| 945 ^p4900^l0^i46710 |
| 999 ^aพรปวีณ์
|